Vaxil Bio Ltd (VXL) — Capital Reinvestment Ratio

Latest as of March 2013: 0.02x

Vaxil Bio Ltd (VXL) has a Capital Reinvestment Ratio of 0.02x as of March 2013, meaning it reinvests 0% of its operating cash flow (CA$658.00) in capital expenditures (CA$14.49). See Vaxil Bio Ltd (VXL) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

CA$658.00

CAD

Capital Expenditures

CA$14.49

CAD

Data as of

Mar 2013

Most recent filing

Annual Capital Reinvestment Ratio for Vaxil Bio Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Vaxil Bio Ltd from None to None. For live market cap and broader valuation context, see VXL stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow